Comprehensive EBITDA Comparison: Hubbell Incorporated vs Rentokil Initial plc

A Decade of EBITDA Growth: Hubbell vs. Rentokil

In the ever-evolving landscape of global business, understanding the financial health of companies is crucial. This chart offers a comprehensive comparison of EBITDA growth between Hubbell Incorporated and Rentokil Initial plc from 2014 to 2023. Over this period, Hubbell has demonstrated a robust growth trajectory, with its EBITDA increasing by approximately 97%, peaking in 2023. Rentokil, while starting from a lower base, has shown a remarkable 182% increase, nearly matching Hubbell's EBITDA by 2023.

Key Insights

• 2014-2018: Hubbell maintained a steady growth, while Rentokil experienced fluctuations, notably in 2018.
• 2019-2023: Both companies saw significant growth, with Rentokil closing the gap.

This analysis highlights the dynamic nature of these companies' financial strategies, offering valuable insights for investors and industry analysts alike.